Despite the enduring pandemic, lockdowns, restrictions and all the other crap that COVID has rained down upon us (I’m a VERY annoyed Melbournian this morning), retail has, for the most part, surprisingly stayed afloat, even thriving in some areas. One of those areas is jewelry. Yep, diamonds remain a girl’s best friend, even when in
Read More
The world could soon have a shortage of disposable gloves with rising COVID cases in Malaysia prompting mass lockdowns, including the halting of operations for manufacturer VIP Gloves (ASX: VIP) which has been one of the biggest beneficiaries from the pandemic. The operational update comes as initial lockdowns in Selangor first introduced on July 3
Read More
Pyjama pant clad Zoom meetings are here to stay (I’m wearing spotty ones today, thanks for asking). The new way we work is uncharted territory for many companies with managers forced to learn on the fly and adapt to the new normal. While we may be hitting our stride on the productivity side of things,
Read More
Home to a population of 110 million with a rapidly growing middle-class, health food company Forbidden Foods (ASX: FFF) has entered the lucrative Philippines market via a distribution deal for their toddler nutrition brand FUNCH and plant-based food brand Sensory Mill. The exclusive distribution deal has been inked with Manila-based Moshi Wellness who have been
Read More
There will be no trophy coming home for English soccer fans but the next best thing for them could be beers delivered to their seats at games with Manchester City engaging sportstech company MSL Solutions (ASX: MSL) for point-of-sale terminals at their stadiums. The 450 POS terminals will be installed at their home ground, Etihad
Read More
Fresh off their recent distribution success of their intravenous, non-opioid based pain medication, AFT Pharmaceuticals (ASX: AFP) has ticked another box announcing the receival of regulatory approval for another form of the drug. The oral liquid form of Maxigesic is a non-opioid based analgesic and extension of AFT’s patented Maxigesic family of medications. The oral
Read More
Readers would know, from the numerous references in my articles, that I’m an oat latte girl. That being said, I do appreciate a good almond cap. But you didn’t come here to read about my coffee order (or maybe you did… If so we’ll get along swimmingly), you came to read about Select Harvests (ASX:
Read More
An extraordinary period for shareholders in meal delivery company Youfoodz (ASX: YFZ) is set to come to a close, albeit many are likely to be disgruntled with the Company recommending a takeover bid from rival HelloFresh at a whopping 57% discount on their IPO price just 8 months earlier. The takeover has come by way
Read More
Retail conglomerate Wesfarmers (ASX: WES) is set to create a new health and wellbeing division to service one of Australia’s fastest growing industries via the acquisition of Australian Pharmaceutical Industries (ASX: API), the operators of Priceline Pharmacies. A non-binding offer has been presented to the Board of API to acquire 100% of the shares on
Read More
Forging ahead with their lead drug candidate, PharmAust (ASX: PAA) is expanding on their COVID-19 program. Their new angle is to investigate the effects of monepantel (MPL) on human T-lymphotropic virus-1 (HTLV-1) infections in partnership with leading biomedical research organisation, the Walter and Eliza Hall Institute (WEHI), based in Melbourne. The HTLV-1 virus is a
Read More
